Literature DB >> 20691262

Nuclear localization of cationic solid lipid nanoparticles containing Protamine as transfection promoter.

Eleonora Vighi1, Monica Montanari, Barbara Ruozi, Giovanni Tosi, Alessandro Magli, Eliana Leo.   

Abstract

Protamine has attracted much attention as DNA condenser and nuclear transfer enhancer although the excess of hydrophilicity and the strong DNA pack restrain its potentialities. In order to overcome this limitation, we added Protamine in the composition of solid lipid nanoparticles (SLN-Protamine) and we compared this carrier with the same kind of SLN containing Esterquat 1 instead of Protamine (SLN-EQ1). Carriers cytotoxicity was assessed on COS-I cells evaluating the cell cycle by propidium iodide test, while the transfection efficiency was studied using pEGFP as plasmid model. The cell penetrating activity of Protamine inside the lipid vectors was evaluated studying cell internalization by confocal microscopy using Red Nile-labeled carriers. SLN-Protamine:pDNA showed a mean diameter five-times smaller than the size of SLN-EQ1:pDNA and a remarkably lesser cytotoxicity. Transfection by SLN-Protamine:pDNA was seven-times more effective compared with the Protamine:pDNA polyplexes while no transfection capacity was observed for SLN-EQ1:pDNA complexes due to their inability to be internalized owing to their larger dimension. Red Nile-SLN-Protamine were localized in endocytic-like vesicles into the nuclear membrane suggesting the inclusion of Protamine in nano-lipophilic systems may enhance the reduction in the complex dimensions, the nuclear pDNA translocation and the pDNA release in the cells.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20691262     DOI: 10.1016/j.ejpb.2010.07.012

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  5 in total

1.  Microcapsules with intrinsic barium radiopacity for immunoprotection and X-ray/CT imaging of pancreatic islet cells.

Authors:  Dian R Arifin; Sameer Manek; Emma Call; Aravind Arepally; Jeff W M Bulte
Journal:  Biomaterials       Date:  2012-03-22       Impact factor: 12.479

Review 2.  Nanoparticle-based technologies for retinal gene therapy.

Authors:  Jeffrey Adijanto; Muna I Naash
Journal:  Eur J Pharm Biopharm       Date:  2015-01-12       Impact factor: 5.571

Review 3.  Protamine-Based Strategies for RNA Transfection.

Authors:  Natalia Teresa Jarzebska; Mark Mellett; Julia Frei; Thomas M Kündig; Steve Pascolo
Journal:  Pharmaceutics       Date:  2021-06-14       Impact factor: 6.321

4.  Ternary nanoparticles composed of cationic solid lipid nanoparticles, protamine, and DNA for gene delivery.

Authors:  Sai-Nan He; Yun-Long Li; Jing-Jing Yan; Wei Zhang; Yong-Zhong Du; He-Yong Yu; Fu-Qiang Hu; Hong Yuan
Journal:  Int J Nanomedicine       Date:  2013-08-07

5.  Design, Characterization, and In Vitro Assays on Muscle Cells of Endocannabinoid-like Molecule Loaded Lipid Nanoparticles for a Therapeutic Anti-Inflammatory Approach to Sarcopenia.

Authors:  Eleonora Maretti; Susanna Molinari; Renata Battini; Cecilia Rustichelli; Eleonora Truzzi; Valentina Iannuccelli; Eliana Leo
Journal:  Pharmaceutics       Date:  2022-03-16       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.